Jiangsu Boxing Pharmaceutical Technology

Jiangsu Boxing Pharmaceutical Technology is a pharmaceutical research and development enterprise based in Taizhou, China, within the China Medical City (CMC) hub. The company focuses on the discovery and development of innovative small molecule therapeutics and high-end generic drugs, particularly in the fields of oncology, cardiovascular diseases, and metabolic disorders. Boxing Pharmaceutical provides a suite of contract research services, including medicinal chemistry, process R&D, and the synthesis of complex pharmaceutical intermediates. The company aims to bridge the gap between laboratory research and commercial production through its integrated technology platforms and experienced scientific leadership. It is recognized as a National High-tech Enterprise and actively engages in technology transfer to advance its pipeline of candidate compounds.